knowledge -WSS

knowledge

author：leisure time 2025-09-30 13:44:25 - browse：35641

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Hospitals are piloting generative AI tools as regulators play catch

WSS

Obamacare plans could cover weight loss drugs

Asbestos, a deadly carcinogen, banned by EPA

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

5 to watch: Tech startups trying to solve health care's staffing crisis

Ukraine seeks to reclaim its role as a hub for clinical trials

A new drug could help frostbite victims avoid its ravages

explore

knowledge

leisure time

Sports medicine is finally prioritizing gender equality

Opioid cravings were reduced by anti

After affirmative action ruling, medical educators look to 'holistic review'

Flagship Pioneering startup Sonata Therapeutics lays off 21

In Memoriam: Notable people who died in 2023

New CMS data security rules will hurt Medicare, Medicaid research

Drug repurposing or repositioning? The language matters

Weight loss drugs aren’t covered by Obamacare. That may change

Trump demands the U.S. pay no more for drugs than other countries … again

SCOTUS questions limit to govt efforts to fight misinformation

leisure time

Intermittent fasting comes with a heart risk? Not so fast

Ukraine seeks to reclaim its role as a hub for clinical trials

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Virtual Event: March of the Biosimilars

Medicare Advantage enrollment hits roughly 33.4 million

Reporting on presidential health from Reagan to Trump and Biden

entertainment

explore

hotspot

hotspot